Atnaujinkite slapukų nuostatas

Escherichia Coli O157 [Kietas viršelis]

, (Kaper & O'Brien)
  • Formatas: Hardback, 492 pages, aukštis x plotis: 178x254 mm, weight: 1233 g
  • Išleidimo metai: 01-Jan-1998
  • Leidėjas: American Society for Microbiology
  • ISBN-10: 1555811299
  • ISBN-13: 9781555811297
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 492 pages, aukštis x plotis: 178x254 mm, weight: 1233 g
  • Išleidimo metai: 01-Jan-1998
  • Leidėjas: American Society for Microbiology
  • ISBN-10: 1555811299
  • ISBN-13: 9781555811297
Kitos knygos pagal šią temą:
Contributors examine the family of bacterial pathogens from such perspectives as epidemiology, animal ecology, food safety, clinical microbiology, gastroenterology, nephrology, infectious disease, toxicology, bacterial pathogenesis, cell biology, and immunology, and draw on experiences ranging from managing farm livestock to managing end-stage renal disease in the clinic. They and their topics reflect rather than present those at a June 1997 symposium and workshop in Baltimore. Among the specific topics are infections in Canada, the bacteria's ecology in cattle and the impact on management practices, interaction with intestinal epithelial cells, cytokine responses, toxicity in human cerebral endothelial cells, various strategies in the immunoprophylaxis of infection and disease, and public health. Annotation c. by Book News, Inc., Portland, Or.
Contributors xi(10) Preface xxi
1. Shiga Toxin-Producing Escherichia coli: Yesterday, Today, and Tomorrow 1(12) Alison D. OBrien James B. Kaper I EPIDEMIOLOGY OF STEC IN HUMANS 13(70)
2. Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Humans in the United States 15(8) Patricia M. Griffin
3. Shiga Toxin-Producing Escherichia coli Infections in Canada 23(7) John S. Spika Rasik Khakhria Pascal Michel Doug Milley Jeff Wilson John Waters
4. Epidemiology of Shiga Toxin-Producing Escherichia coli in South America 30(8) Eduardo L. Lopez Maria Marta Contrini Maria Fabiana De Rosa
5. Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Continental Europe 38(11) Alfredo Caprioli Alberto Eugenio Tozzi
6. Shiga Toxin (Verocytotoxin)-Producing Escherichia coli in the United Kingdom 49(10) Henry R. Smith Bernard Rowe Goutam K. Adak William J. Reilly
7. An Outbreak of Escherichia coli O157: H7 in Central Scotland 59(7) Syed Ahmed Martin Donaghy
8. Shiga Toxin-Producing Escherichia coli in Australia 66(7) Roy M. Robins-Browne Elizabeth Elliott Patricia Desmarchelier
9. Recent Outbreaks of Infections Caused by Escherichia coli O157:H7 in Japan 73(10) Hideshi Michino Kazuhiro Araki Shunsaku Minami Tomonori Nakayama Yuichiro Ejima Kazunori Hiroe Hiroshi Tanaka Noriya Fujita Satosi Usami Masakazu Yonekawa Koich Sadamoto Satoshi Takaya Nobumichi Sakai II STEC IN THE FOOD CHAIN 83(36)
10. Ecology of Escherichia coli O157:H7 in Cattle and Impact of Management Practices 85(7) Dale D. Hancock Thomas E. Besser Daniel H. Rice
11. Microbiology of Shiga Toxin-Producing Escherichia coli in Foods 92(17) Jianghong Meng Michael P. Doyle
12. Food Safety in the United States 109(10) Jill Hollingsworth Bruce Kaplan III PATHOGENIC MECHANISMS: BACTERIAL FACTORS 119(92)
13. Structure, Biology, and Relative Toxicity of Shiga Toxin Family Members for Cells and Animals 121(8) Angela R. Melton-Celsa Alison D. OBrien
14. Shiga Toxin (Verotoxin) Binding to Its Receptor Glycolipid 129(11) C.A. Lingwood M. Mylvaganam S. Arab A.A. Khine G. Magnusson S. Grinstein P.-G. Nyholm
15. Shiga Toxin Interaction with Intestinal Epithelial Cells 140(8) David W. K. Acheson Lisa L. Lincicome Mary S. Jacewicz Gerald T. Keusch
16. Intimin-Mediated Adherence of Shiga Toxin-Producing Escherichia coli and Attaching-and-Effacing Pathogens 148(9) James B. Kaper Lisa J. Gansheroff Marian R. Wachtel Alison D. OBrien
17. Intimin-Independent Adherence Mechanisms of Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 157(6) Phillip I. Tarr Sima S. Bilge
18. Attaching-and-Effacing Intestinal Histopathology and the Locus of Enterocyte Effacement 163(20) James B. Kaper Simon Elliott Vanessa Sperandio Nicole T. Perna George F. Mayhew Frederick R. Blattner
19. Plasmid-Encoded Determinants of Escherichia coli O157:H7 183(12) Helge Karch Herbert Schmidt Werner Brunder
20. Evolution of Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 195(16) Thomas S. Whittam IV PATHOGENIC MECHANISMS: HOST RESPONSE AND ANIMAL MODELS 211(74)
21. Epithelial Cell Responses to Shiga Toxin-Producing Escherichia coli Infection 213(13) Arif Ismaili Dana J. Philpott Derek M. McKay Mary H. Perdur Philip M. Sherman
22. Cytokine Response to Shiga Toxins 226(10) Vernon L. Tesh
23. Human Immune Response and Immunity to Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infection 236(13) Mohamed A. Karmali
24. Overview of Animal Models 249(12) Rodney A. Moxley David H. Francis
25. Bovine Infection with Shiga Toxin-Producing Escherichia coli 261(7) Evelyn A. Dean-Nystrom Brad T. Bosworth Harley W. Moon Alison D. OBrien
26. Canine Model of Hemolytic-Uremic Syndrome 268(10) Brad W. Fenwick Laine A. Cowan
27. Interleukin-1 Receptor Antagonist Protects against Tissue Injury in an Animal Model of Hemorrhagic Colitis 278(7) Peter D. Bloom Robert G. Russell Edgar C. Boedeker V PATHOGENESIS OF HEMOLYTIC-UREMIC SYNDROME 285(44)
28. Pathophysiology of Hemolytic-Uremic Syndrome 287(6) Leo Monnens C.O. Savage C. M. Taylor
29. Hematology of Hemolytic-Uremic Syndrome 293(10) Peter Rose Ian Chant
30. Interaction of Shiga Toxins with Endothelial Cells 303(9) Tom G. Obrig
31. Novel Role of Basic Fibroblast Growth Factor in the Pathogenesis of Classic Hemolytic-Uremic Syndrome 312(11) Patricio E. Ray Angel Onorio Jorge Sgromo Silvana Maglio Irene Marco Xue-Hui Liu Lian Xu Guillermo E. Gallo
32. Shiga Toxin (Verotoxin) Toxicity in Human Cerebral Endothelial Cells 323(6) James S. Hutchison Danica Stanimirovic Anthony Shapiro Glen D. Armstrong VI DIAGNOSIS AND TREATMENT OF STEC INFECTIONS 329(74)
33. Overview of Detection and Subtyping Methods 331(26) Nancy A. Strockbine Joy G. Wells Cheryl A. Bopp Timothy J. Barrett
34. Treatment of Disease Due to Shiga Toxin-Producing Escherichia coli: Infectious Disease Management 357(7) Marguerite A. Neill
35. Principles of the Treatment of Shiga Toxin-Associated Hemolytic-Uremic Syndrome: Pay Meticulous Attention to Detail, and Do No Harm 364(10) Kevin E.C. Meyers Seth L. Schulman Bernard S. Kaplan
36. Clinical Trials of Synsorb-Pk in Preventing Hemolytic-Uremic Syndrome 374(11) Glen D. Armstrong Peter N. McLaine Peter C. Rowe
37. Early Use of Fosfomycin for Shiga Toxin-Producing Escherichia coli O157 Infection Reduces the Risk of Hemolytic-Uremic Syndrome 385(3) Tae Takeda Ken-ichi Yoshino Hiroshi Uchida Norikazu Ikeda Masako Tanimura
38. Vero Cell Neutralization and Mouse Protective Efficacy of Humanized Monoclonal Antibodies against Escherichia coli Toxins Stx1 and Stx2 388(5) Ana C. Edwards Angela R. Melton-Celsa Kathy Arbuthnott Jeffrey R. Stinson Clare K. Schmitt Hing C. Wong Alison D. OBrien
39. Shiga Toxin-Producing Escherichia coli Infections: Challenges and Opportunities 393(10) Phillip I. Tarr VII VACCINES AGAINST STEC 403(50)
40. Immunoprophylaxis of Shiga Toxin-Producing Escherichia coli Infection and Disease: Strengths and Weaknesses of Various Strategies 405(4) Myron M. Levine
41. Toxoid-Based Active and Passive Immunization To Prevent and/or Modulate Hemolytic-Uremic Syndrome Due to Shiga Toxin-Producing Escherichia coli 409(10) Gerald T. Keusch David W. K. Acheson Colin Marchant James McIver
42. Synthesis and Immunologic Properties of O-Specific Polysaccharide-Protein Conjugate Vaccines for Prevention and Treatment of Infections with Escherichia coli O157 and Other Causes of Hemolytic-Uremic Syndrome 419(6) Edward Konadu James C. Parke, Jr Arthur Donohue-Rolfe Stephen B. Calderwood John B. Robbins Shousun C. Szu
43. Live, Oral Attenuated Vaccine Vectors for Prevention of Shiga Toxin-Producing Escherichia coli Infection 425(9) Joan R. Butterton Stephen B. Calderwood
44. Vaccines and Shiga Toxin-Producing Escherichia coli in Animals 434(11) C. L. Gyles
45. Public Health Perspective on Immunoprophylactic Strategies for Escherichia coli O157:H7: Who or What Would We Immunize? 445(8) Robert V. Tauxe Index 453